One concentrated allocation, a massive backlog, and a takeover price hanging over the stock make this one of the more revealing institutional moves this quarter.

Did Blue Prince get too esoteric with its puzzles? Was its randomness too punitive and player-unfriendly? Two A.V. Club ...

Tennessee has arrived in the mid-state for another appearance in the Music City Bowl this evening, set to play Illinois out ...

Preparing for retirement involves a complex set of decisions, with prospective retirees relying on estimates of how long ...

It's almost 2026, and soon you'll be receiving your year-end statements for all your investment accounts. You'll also hear a ...

Adapted from Andy West’s memoir The Life Inside, the drama follows a philosopher who begins teaching a class of men in prison ...

The longtime horoscope personality on how she arrives at her predictions and what the stars tell us about unrest in the year ...

Aehr Test Systems faces near-term headwinds from customer uncertainty, weak backlog, and margin compression. Read why AEHR stock is a Hold.

The BioMarin Pharmaceutical Inc. acquisition of Amicus Therapeutics, Inc. will likely be beneficial and accretive for both ...

After announcing that he was entering the draft, Niblack thanked Texas A&M and Alabama for their impact on his career. He did ...

Despite the sharp correction in the Nifty IT index, DIIs are buying IT stocks at an aggressive pace. Are they looking beyond ...

First released on the 1970 album In Rock, “Child In Time” featured Ritchie Blackmore, Gillan, Jon Lord, and Ian Paice. At the time of its release, the song landed No. 1 on the Australian Albums chart.